Trovagene (NASDAQ: TROV), which started out as a diagnostics company, has renamed itself Cardiff Oncology to better reflect its focus on the cancer drug it is advancing in three clinical trials. In 2017 the San Diego area-based biotech made the first step in its transformation into a drug development-focused organization, licensing rights to an investigational cancer drug from […]

A Triangle drugmaker is beginning trials for a potential treatment for Covid-19 while at the same time the company is close to locking down a federal contract to stockpile treatments for another deadly disease […]

CLEVELAND, Ohio (WOIO) – University Hospitals and Athersys, a Cleveland based biotech company, have announced the start of the Macovia study, a clinical trial that will test the effectiveness of cell therapy for COVID-19 patients suffering from Acute Respiratory Distress Syndrome (ARDS) which is the leading cause of death for COVID-19 patients. ARDS is a […]